Has further downside to $11-$14 - Gap fill from October 19' ショート

詳細

⋅ 2020年2月10日午後9時43分

The recent plummet was due to less than stellar Phase 3 results. With a March 25 PDUFA target on the horizon, longs may have given up and cut their losses. Technical indicate a big gap to fill in the $11-$14 area from October last year. Short.

fsanyot1

⋅ 2020年2月24日午後5時15分

This is dumb. Their PDUFA is for a different disease (Dravet Syndrome) while the data is about Lennox-Gestaut syndrome. Long.

SimplyCash

⋅ 2020年2月27日午前1時49分

@fsanyot1, Still long?

詳細